Ullrich Bethe
Impact in
- Hepatology top 0.5%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Surgical Treatments
- Cancer Treatment and Pharmacology
Papers in
- Oncology 14
- Colorectal Cancer Treatments and Studies 6
- Neutropenia and Cancer Infections 5
-
- Antifungal resistance and susceptibility 4
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Eric Van Cutsem (5 shared papers)Michel Praet (3 shared papers)Meg Finch-Jones (3 shared papers)Thomas Gruenberger (3 shared papers)Bernard Nordlinger (3 shared papers)John Primrose (3 shared papers)Bengt Glimelius (2 shared papers)Graeme J. Poston (1 shared paper)
In The Last Decade
Ullrich Bethe
27 papers receiving 2.0k citations
Ullrich Bethe's Hit Papers
Peers
Comparison fields: 5 of 82
- Hepatology 1.2k
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 508
- Surgery 587
- Otorhinolaryngology 43
Countries citing papers authored by Ullrich Bethe
This map shows the geographic impact of Ullrich Bethe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullrich Bethe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullrich Bethe more than expected).
Fields of papers citing papers by Ullrich Bethe
This network shows the impact of papers produced by Ullrich Bethe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullrich Bethe. The network helps show where Ullrich Bethe may publish in the future.
Co-authors
The 25 scholars most cited alongside Ullrich Bethe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial Hit paper breakdown → | 2008 | 1396 |
| 2 | 2007 | 127 | |
| 3 | 2014 | 76 | |
| 4 | 2003 | 57 | |
| 5 | 2002 | 49 | |
| 6 | 2004 | 46 | |
| 7 | 2007 | 46 | |
| 8 | 2011 | 45 | |
| 9 | 2002 | 36 | |
| 10 | 2004 | 26 | |
| 11 | 2006 | 25 | |
| 12 | 2006 | 13 | |
| 13 | 2001 | 12 | |
| 14 | 2001 | 9 | |
| 15 | Risk factors for the HIV-associated lipodystrophy syndrome in a cross-sectional single-centre study. | 2000 | 9 |
| 16 | 2022 | 9 | |
| 17 | 2021 | 6 | |
| 18 | 2005 | 6 | |
| 19 | 2012 | 6 | |
| 20 | 2011 | 4 |
About Ullrich Bethe
Ullrich Bethe is a scholar working on Oncology, Infectious Diseases, Pulmonary and Respiratory Medicine, Epidemiology and Molecular Biology, having authored 30 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (6 papers), Neutropenia and Cancer Infections (5 papers), Bacterial Identification and Susceptibility Testing (4 papers), Head and Neck Cancer Studies (4 papers), Antifungal resistance and susceptibility (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Fungal Infections and Studies (3 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Hepatology (1.2k citations), Oncology (1.5k citations), Pulmonary and Respiratory Medicine (508 citations), Surgery (587 citations) and Otorhinolaryngology (43 citations). Ullrich Bethe has collaborated with scholars based in Germany, Belgium and Spain. Frequent co-authors include Eric Van Cutsem, Michel Praet, Meg Finch-Jones, Thomas Gruenberger, Bernard Nordlinger, John Primrose, Bengt Glimelius, Graeme J. Poston, Laurence Collette and Halfdan Sørbye. Their work appears in journals such as Journal of Clinical Oncology, Annals of Hematology, Annals of Oncology, Infection and Infection Control and Hospital Epidemiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.